It has also been shown that in ccRCC, CXCL13+CD8+ T cell abundance impairs total CD8+ T cell function, and CXCL13+CD8+ T cell infiltration indicates poorer clinical outcomes in ccRCC patients (Dai et al., 2021). The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.